Table: Kubota Pharmaceutical Holdings -9-MTH group results (IFRS)

Kubota Pharmaceutical Holdings

09/11/2017 06:00

Nov 9 (Reuters)-  
              Kubota Pharmaceutical Holdings Co., Ltd.  
              CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)  
                   9 months ended      9 months ended        Year to    
                  Sep 30, 2017        Sep 30, 2016       Dec 31, 2017   
                     LATEST             YEAR-AGO           COMPANY      
                     RESULTS             RESULT            FORECAST     
  Sales               0 mln              818 mln            0 mln       
  Operating         loss 2.92           loss 3.28         loss 4.29     
  Pretax            loss 2.79           loss 3.16         loss 4.18     
  Net               loss 2.79           loss 3.17         loss 4.18     
  EPS Basic      loss 73.74 yen      loss 84.88 yen    loss 110.00 yen  
  EPS Diluted    loss 73.74 yen      loss 84.88 yen                     
  Ann Div                                  NIL               NIL        
  -Q2 Div              NIL                 NIL                          
  -Q4 Div                                  NIL               NIL        
  
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd..  
  (Figures are reported based on international accounting rules (IFRS).)  
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half  
  dividend and Q4 to the second-half dividend announced before a new corporate law in  
  2006 allowed companies to pay and report dividends on a quarterly basis. 
  *Net - represents Net profit attributable to owners of the parent company.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T  
  ((Tokyo Headline News Desk +813 6441 1812))